Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
OTC Markets
03:37:28 03/06/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0620 USD | -7.32% |
|
+7.36% | +10.91% |
| Market Cap | 22.53M 19.37M 18.28M 16.65M 31.13M 2.15B 31.41M 218M 83.78M 1.09B 84.59M 82.74M 3.47B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25.25M 21.72M 20.49M 18.67M 34.9M 2.41B 35.21M 244M 93.93M 1.22B 94.84M 92.76M 3.89B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Provectus Biopharmaceuticals, Inc.
| 1 day | -7.32% | ||
| 1 week | +7.36% | ||
| Current month | +9.66% | ||
| 1 month | +4.03% | ||
| 3 months | -9.62% | ||
| 6 months | +8.77% | ||
| Current year | +10.91% |
| 1 week | 0.05 |  | 0.07 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.09 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/9/26 | Exercice | Chief Executive Officer | -11,328 | 0.1200% | ||
| 26/8/26 | Exercice | Chief Executive Officer | -11,328 | 0.1200% | ||
| 30/6/26 | Free | Director | 48,917 | 0.5182% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.32% | +7.36% | -11.43% | -43.28% | 22.53M | |
| -2.11% | -3.44% | +41.04% | +98.48% | 68.24B | |
| -0.23% | -4.45% | +30.39% | +73.64% | 62.23B | |
| -0.16% | +0.71% | -12.76% | +379.96% | 27.8B | |
| -1.05% | -7.30% | +25.00% | +12.31% | 24.86B | |
| +0.87% | -6.66% | -7.15% | -17.89% | 24.22B | |
| +0.43% | -3.37% | +14.85% | -19.29% | 19.36B | |
| -3.03% | -5.19% | +192.88% | +340.13% | 17.28B | |
| -1.94% | -6.36% | -7.05% | +516.16% | 14.46B | |
| -2.02% | -4.42% | +44.36% | +156.48% | 14.23B | |
| Average | -1.64% | -3.56% | +31.01% | +149.67% | 27.27B | |
| Weighted average by Cap. | -0.97% | -3.80% | +32.77% | +135.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.53 0.5 0.46 0.85 59 0.86 5.96 2.3 29.93 2.32 2.27 95.06 | 0.34 0.29 0.27 0.25 0.46 32.13 0.47 3.25 1.25 16.3 1.26 1.23 51.77 |
| Net income | -4.76M -4.1M -3.86M -3.52M -6.58M -455M -6.64M -46.02M -17.71M -231M -17.88M -17.49M -734M | -5.43M -4.67M -4.41M -4.01M -7.5M -519M -7.57M -52.48M -20.2M -263M -20.39M -19.95M -837M |
| Net Debt | 2.88M 2.47M 2.33M 2.13M 3.98M 275M 4.01M 27.81M 10.7M 140M 10.8M 10.57M 443M | 2.73M 2.35M 2.21M 2.02M 3.77M 261M 3.8M 26.36M 10.14M 132M 10.24M 10.02M 420M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | US$0.0536 | +1.71% | 177,617 |
| 09/09/26 | US$0.0527 | -0.75% | 52,072 |
| 08/09/26 | US$0.0531 | -11.50% | 207,865 |
| 04/09/26 | US$0.0600 | +3.90% | 70,811 |
| 03/09/26 | US$0.0578 | -1.45% | 7,450 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
